DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 35 filers reported holding DIAMEDICA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $435,323 | -49.3% | 168,730 | -15.1% | 0.61% | -36.6% |
| Q2 2023 | $858,514 | +140.1% | 198,730 | -15.0% | 0.97% | +132.1% |
| Q1 2023 | $357,607 | -3.2% | 233,730 | 0.0% | 0.42% | -7.3% |
| Q4 2022 | $369,293 | +24.8% | 233,730 | -2.0% | 0.45% | +39.8% |
| Q3 2022 | $296,000 | -38.6% | 238,500 | 0.0% | 0.32% | -33.9% |
| Q2 2022 | $482,000 | -27.3% | 238,500 | -10.0% | 0.49% | +20.8% |
| Q1 2022 | $663,000 | -35.4% | 265,000 | -3.6% | 0.40% | -12.0% |
| Q4 2021 | $1,026,000 | -7.0% | 275,000 | 0.0% | 0.46% | +14.2% |
| Q3 2021 | $1,103,000 | -9.9% | 275,000 | 0.0% | 0.40% | -0.7% |
| Q2 2021 | $1,224,000 | -27.7% | 275,000 | +48.6% | 0.40% | -38.4% |
| Q1 2021 | $1,693,000 | +19.2% | 185,000 | +32.1% | 0.66% | -38.9% |
| Q4 2020 | $1,420,000 | – | 140,000 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 419,942 | $1,869,000 | 0.98% |
| Manatuck Hill Partners, LLC | 570,500 | $2,539,000 | 0.77% |
| Corriente Advisors, LLC | 203,641 | $906,000 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 275,000 | $1,224,000 | 0.40% |
| Ikarian Capital, LLC | 415,000 | $1,847,000 | 0.15% |
| COOPERMAN LEON G | 50,000 | $223,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 46,562 | $207,000 | 0.01% |
| Trexquant Investment LP | 17,019 | $76,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 30,511 | $136,000 | 0.00% |
| MARSHALL WACE, LLP | 155,662 | $693,000 | 0.00% |